Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer

(2010) S L Cooke et al.   BRITISH JOURNAL OF CANCER

Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease

(2010) Andrew N. Priest et al.   MAGNETIC RESONANCE IN MEDICINE

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma

(2010) S L Cooke et al.   ONCOGENE

Multiparametric Imaging of Tumor Response to Therapy

(2010) Anwar R. Padhani et al.   RADIOLOGY

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

(2009) AD Barker et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla

(2009) Evis Sala et al.   EUROPEAN RADIOLOGY

Metabolic characterization of primary and metastatic ovarian cancer by1H-MRS in vivo at 3T

(2009) Mary A. McLean et al.   MAGNETIC RESONANCE IN MEDICINE

Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1  Signaling in a Human Prostate Cancer Model

(2008) K. Glunde et al.   CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Semiquantitative and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging Measurements Predict Radiation Response in Cervix Cancer

(2008) Mark A. Zahra et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS